Exclusive

Publication

Byline

Singapore Clinical Trial: Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant monotherapy compared with standard of care in patients with early-stage, resectable non-small cell lung cancer (Stage II-IIIB) harboring tyrosine kinase domain activating HER2 mutations

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant ... Read More


Clinical Trial: Testing the Impact of the Parenting Young Children Check-up

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07750054) titled 'Testing the Impact of the Parenting Young Children Check-up' on July 23. Brief Summary: The... Read More


Clinical Trial: Mobile Health Intervention to Increase Activity in Heart Failure Study

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07750262) titled 'Mobile Health Intervention to Increase Activity in Heart Failure Study' on July 25. Brief S... Read More


Clinical Trial: Enhancing Cognitive and Work/School Outcomes in First Episode Psychosis Using Cognitive Self-Management Strategies

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749105) titled 'Enhancing Cognitive and Work/School Outcomes in First Episode Psychosis Using Cognitive Self... Read More


Singapore Clinical Trial: A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the effects of oral TRPC6 inhibitor BI 764198 taken over a 104 week treatment period in adult and adolescent participants with primary focal segmental glomerulosclerosis (pFSGS) or genetic FSGS related to TRPC6 gene variants

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the eff... Read More


Clinical Trial: Hydrodissection-Assisted Bipolar Prostatic Enucleation Versus Conventional Bipolar Enucleation

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749794) titled 'Hydrodissection-Assisted Bipolar Prostatic Enucleation Versus Conventional Bipolar Enucleati... Read More


Singapore Clinical Trial: A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the effects of oral TRPC6 inhibitor BI 764198 taken over a 104 week treatment period in adult and adolescent participants with primary focal segmental glomerulosclerosis (pFSGS) or genetic FSGS related to TRPC6 gene variants

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the eff... Read More


Singapore Clinical Trial: A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate... Read More


Clinical Trial: Figuring Out the Genetic Mutations That Lead to Lower Jaw Advancement More Than the Upper Jaw

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749638) titled 'Figuring Out the Genetic Mutations That Lead to Lower Jaw Advancement More Than the Upper Ja... Read More


Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants with Obesity or Overweight who are Otherwise Healthy.

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate th... Read More